tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Daiichi Sankyo Company Limited (DSKYF)
OTHER OTC:DSKYF
US Market
DSKYF
Daiichi Sankyo Company
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Daiichi Sankyo Company (DSKYF) Stock News & Sentiment

Compare
51 Followers
AstraZeneca’s Ongoing Study on New Breast Cancer Treatment Shows Promise
Premium
Company Announcements
AstraZeneca’s Ongoing Study on New Breast Cancer Treatment Shows Promise
1M ago
AZN
Daiichi Sankyo’s Promising Future: Buy Rating Backed by ADC Advancements and Strategic Growth Initiatives
Premium
Ratings
Daiichi Sankyo’s Promising Future: Buy Rating Backed by ADC Advancements and Strategic Growth Initiatives
4M ago
Daiichi Sankyo Reports Strong Fiscal Year Growth
Premium
Company Announcements
Daiichi Sankyo Reports Strong Fiscal Year Growth
4M ago
Daiichi Sankyo Reports Robust Q3 Earnings Performance
Premium
Company Announcements
Daiichi Sankyo Reports Robust Q3 Earnings Performance
7M ago
DSKYF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
DSKYF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Merck (NYSE:MRK) Slides after “Guided Missile” Cancer Drug Is Declined
Premium
Market News
Merck (NYSE:MRK) Slides after “Guided Missile” Cancer Drug Is Declined
1y ago
MRK
Merck (NYSE:MRK) Joins Hands with Daiichi Sankyo to Develop Cancer Drugs
Premium
Market News
Merck (NYSE:MRK) Joins Hands with Daiichi Sankyo to Develop Cancer Drugs
2y ago
MRK
More DSKYF News >

DSKYF News on the Web

Congress Trade: Representative Gilbert Ray Cisneros, Jr. Just Disclosed New Stock Trades
Quiver Quantitative
Neutral
Morgan Stanley Remains a Buy on Daiichi Sankyo Company (DSKYF)
TipRanks News
Neutral
Daiichi Sankyo Reports Strong Fiscal Year Growth
TipRanks News
Neutral
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY-Gastric04 Phase 3 Trial
Yahoo Finance
Neutral
ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy
Yahoo Finance
Neutral
Survey Reveals: 88% of Western Europeans Would Like Better Information on Breast Cancer, Misconceptions and Lack of Awareness of the Disease Still Prevail
Yahoo Finance
Neutral
Datopotamab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Yahoo Finance
Neutral
ENHERTU® Approved in the U.S. as First HER2 Directed Therapy for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following Disease Progression After One or More Endocrine Therapies
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
DSKYF
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DSKYF’s Media Buzz Sentiment?
Currently, no data Available
What is DSKYF’s weekly average amount of articles?
Currently, no data Available
What is DSKYF’s News Sentiment?
59% of articles about DSKYF were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    HALOHalozyme
    UTHRUnited Therapeutics
    KNSAKiniksa Pharmaceuticals
    PHRPhreesia
    PNTGPennant Group
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing